Evidence map›Paper›PMID 27909229›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2017

Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction.

Steven K Nishiyama, Jia Zhao, D Walter Wray, Russell S Richardson

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  7. Article
  8. Endothelin-1/endothelin B receptor signalling mediates Prx1Journal of orthopaedic translation · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Cardiovascular Biomarkers: Tools for Precision Diagnosis and Prognosis.International journal of molecular sciences · 2025
    Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Steven K NishiyamaCollege of Osteopathic Medicine, Touro University, Henderson, Nevada.
Jia ZhaoDepartment of Medicine, Division of Geriatrics, University of Utah, Salt Lake City, Utah.
D Walter WrayDepartment of Medicine, Division of Geriatrics, University of Utah, Salt Lake City, Utah.
Russell S RichardsonDepartment of Medicine, Division of Geriatrics, University of Utah, Salt Lake City, Utah; r.richardson@hsc.utah.edu.
University of Utah · USTouro University Nevada · US

Funding

Peripheral Vasoconstriction in Heart Failure: Mechanisms & Modulatory InfluencesR01HL118313 · NHLBI · UNIVERSITY OF UTAH · PI WRAY, D. WALTER · 2014 to 2018
$1.9M
Passive limb movement: A tool to assess vascular health and guide rehabilitationI01RX001697 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI RICHARDSON, RUSSELL S. · 2015 to 2018
–
Contribution of Endothelin-1 to Exercise Intolerance in HFI21RX001418 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI WRAY, D. WALTER · 2015 to 2015
–
NHLBI NIH HHS R01 HL118313RRD VA I01 RX001697RRD VA I21 RX001418
6 · The paper itself

Abstract

Endothelin-1 (ET-1), a potent vasoconstrictor secreted by vascular endothelial cells, has been implicated in the pathophysiology of numerous cardiovascular diseases, yet the direct impact of ET-1 on vascular function remains unclear. Therefore, in seven young (23 ± 1 yr) healthy subjects, we investigated the effect of an intra-arterial infusion of ET-1 on reactive hyperemia (RH) and flow-mediated dilation (FMD) in the popliteal artery following 5 min of suprasystolic cuff occlusion. ET-1 infusion significantly attenuated basal leg blood flow (control: 62 ± 4 ml/min, ET-1: 47 ± 9 ml/min), RH [area-under-curve (AUC); control: 162 ± 15 ml, ET-1: 104 ± 16 ml], and peak RH (control: 572 ± 51 ml/min, ET-1: 412 ± 32 ml/min) (

Indexed as

AdultEndothelin-1Endothelium, VascularExerciseFemaleHumansHyperemiaInfusions, Intra-ArterialLegMaleNitric OxidePopliteal ArteryRegional Blood FlowVasoconstrictionVasoconstrictor AgentsVasodilationEndothelin-1Nitric OxideVasoconstrictor Agentscardiovascular diseaseendotheliumflow-mediated dilationvascular function

Identifiers

PMID27909229
PMCPMC5338602
OpenAlexW2559024377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.